Millennium Management »

Biomarin Pharmaceutical shares owned by Millennium Management

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Millennium Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $24M 25M 0.95

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Meta Platforms Cl A (META)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Financial Call Option (XLF)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)

View all positions for Millennium Management

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Ing Investment Management
BlackRock
MacKay Shields
Opti Capital Management
Capstone Investment Advisors
Wellesley Investment Advisors
Millennium Management
Lazard Asset Management
Oaktree Capital Management
Victory Capital Management
Bnp Paribas Arbitrage, Snc
Thrivent Financial for Lutherans
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

View all funds holding Biomarin Pharmaceutical